Exact Mass: 381.0226
Exact Mass Matches: 381.0226
Found 63 metabolites which its exact mass value is equals to given mass value 381.0226,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one
Desacetycefapirin
Desacetycefapirin is a potential milk contaminant arising from the metabolism of cefapirin in cattle. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams Potential milk contaminant arising from the metabolism of cefapirin in cattle
5'-Carboxy meloxicam
5-Carboxy meloxicam is a metabolite of meloxicam. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and fever reducer effects. It is a derivative of oxicam, closely related to piroxicam, and falls in the enolic acid group of NSAIDs. It was developed by Boehringer-Ingelheim. (Wikipedia)
N-Acetylgalactosamine 4,6-disulfate
N-Acetylgalactosamine 4,6-disulfate (GalNAc4,6diS) is one of the sulphated N-acetylhexosamines that have been isolated from human urine. PMID: 3931626. N-Acetylgalactosamine 4,6-disulfate (GalNAc4,6diS)is one of the sulphated N-acetylhexosamines that have been isolated from human urine.
dehydrofelodipine
dehydrofelodipine is a metabolite of felodipine. Felodipine is a calcium channel blocker (calcium antagonist), a drug used to control hypertension (high blood pressure). It is marketed under the brand name Plendil by AstraZeneca and Renedil by Sanofi-Aventis. The formulation patent for the substance expired in 2007. AstraZeneca dropped Plendil from its support and AZ&Me free Rx access program in October 2008. (Wikipedia)
Cimicoxib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
2-(4-(2-((3,5-Dichlorophenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid
(+)-(6R,8S)-1-thiomethyldiscorhabdin G*/I trifluoroacetate
PRZ_M382
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2012
O,O-Diethylthiophosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate
4-(4-chlorophenylmethyl)-6,7-dimethoxy-isoquinoline methanesulfonate (1:1)
NXY-059
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D020011 - Protective Agents > D000975 - Antioxidants C26170 - Protective Agent > C275 - Antioxidant D002317 - Cardiovascular Agents
Platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane
Mebutizide
C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic
5-[(4-acetylbenzoyl)amino]-2-ethoxybenzenesulfonyl chloride
(6R,7R)-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8- oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
[5-(4-chlorophenoxy)-3-[3-(trifluoromethyl)phenyl]-1,2,4-triazin-6-yl]methanol
2-amino-5-formylamino-6-(5-phosphoribosylamino)pyrimidin-4(3H)-one
((2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(4-nitrophenoxy)tetrahydro-2H-pyran-2-yl)methyl dihydrogen phosphate
2-(4-(2-((3,5-Dichlorophenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoic acid
(5Z)-5-(3-Bromocyclohexa-2,5-dien-1-ylidene)-N-(pyridin-4-ylmethyl)-1,5-dihydro[1,2,4]triazolo[1,5-A]pyrimidin-7-amine
N-(hydroxymethyl)-N-{propyl[2-(2,4,6-trichlorophenoxy)ethyl]carbamoyl}methanimidamide
(4S)-2-acetyl-3,4,8,10,11,12-hexahydroxy-1,4-dihydrotetracen-1-one
[4,5-Dihydroxy-9,10-dioxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetate
2-acetamido-2-deoxy-4,6-di-O-sulfo-beta-D-galactopyranose
[(1S)-2-[2-[(2R)-2-amino-2-carboxyethyl]seleninyl-1H-imidazol-5-yl]-1-carboxyethyl]-trimethylazanium
2-[[[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxy-hydroxyphosphoryl]methylamino]acetic acid
N-[(3-benzamidoanilino)-sulfanylidenemethyl]-2-thiophenecarboxamide
N-[[3-chloro-4-(4-morpholinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-dibenzofuransulfonamide
4,5-Dichloro-2-[2-[2,5-dimethyl-1-(2,2,2-trifluoroethyl)-3-pyrrolyl]-2-oxoethyl]-3-pyridazinone
5-(1,3-benzodioxol-5-yl)-3-phenyl-2-sulfanylidene-4H-thiazolo[4,5-d]pyrimidin-7-one
4-[[(3,6-Dichloro-2-methoxyphenyl)-oxomethyl]amino]benzoic acid propyl ester
(E)-2-methylsulfonyl-3-[1-(4-nitrophenyl)sulfonylpyrrol-2-yl]prop-2-enenitrile
6-(Bromomethyl)-1,3-dimethyl-5-[(4-nitrophenyl)-oxomethyl]pyrimidine-2,4-dione
3-chloro-6-ethyl-N-(1H-indol-3-ylmethylene)-1-benzothiophene-2-carbohydrazide
2,3-Dihydro-1,4-benzodioxin-6-carboxylic acid [2-(2,5-dichloroanilino)-2-oxoethyl] ester
2-(7-Bromo-1-methyl-5-triazolo[4,5-c]pyridin-5-iumyl)-1-(2-naphthalenyl)ethanone
N-{5-bromo-1-[2-(morpholin-4-yl)ethyl]-2-oxo-2,3-dihydro-1H-indol-3-yl}acetamide
4-[(5Z)-5-[(Z)-2-Methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzoic acid
4-chloro-N-[(2S)-5-hydroxy-2-methyl-2,3-dihydroindol-1-yl]-3-sulfamoylbenzamide
N-[2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxotetrazol-1-yl]phenyl]ethanesulfonamide
Cimicoxib
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor
Desacetycefapirin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
